Related Experiment Video
Updated: Jun 14, 2026
07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Long QT syndrome: A therapeutic challenge
Maully Shah1, Christopher Carter
1The Cardiac Center, The Children's Hospital of Philadelphia, Philadelphia, USA.
Annals of Pediatric Cardiology
|March 20, 2010
Summary
Congenital long QT syndrome (LQTS), a common cardiac channelopathy, causes dangerous arrhythmias. Genetic identification allows for tailored therapies, with beta blockers remaining the primary treatment.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Congenital long QT syndrome (LQTS) is a prevalent cardiac channelopathy.
- It is characterized by prolonged ventricular repolarization, leading to life-threatening arrhythmias and high mortality in untreated individuals.
- Genetic discoveries have significantly advanced LQTS management strategies.
Purpose of the Study:
- To highlight the impact of genetic identification in congenital long QT syndrome.
- To discuss the established genotype-phenotype correlations and their role in guiding therapy.
- To review current and emerging therapeutic options for LQTS patients.
Main Methods:
- Review of current literature on congenital long QT syndrome genetics and management.
- Analysis of genotype-phenotype correlations in LQTS.
- Synthesis of data on therapeutic interventions.
Main Results:
- Identification of multiple LQTS genes has enabled genotype-specific therapies.
- A strong correlation between genotype and phenotype has been observed.
- Beta blockers are the cornerstone of arrhythmia prevention for most patients.
Conclusions:
- Genetic testing is crucial for personalized LQTS management.
- Genotype-guided therapies improve patient outcomes.
- A multi-faceted approach including medications, devices, and lifestyle modifications is essential for comprehensive LQTS care.
Related Concept Videos
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.